20 articoli
Comprehensive review of 36 studies reveals BPC-157's potential for accelerating recovery from muscle, tendon, and bone injuries.
A comprehensive review reveals BPC-157 lacks validated formulations, human PK data, and a coherent drug development path despite 30+ years of preclinical research.
Synthetic peptide demonstrates healing effects across multiple tissues in preclinical models, but human data remains limited.
Commentary examines the therapeutic potential of BPC-157, a natural 15-amino acid peptide with remarkable cytoprotective properties.
A comprehensive review reveals BPC-157's clinical translation is blocked not by lack of biological activity, but by absent pharmaceutical development.
Synthetic peptide demonstrates powerful tissue repair in animals, but human trials remain extremely limited despite growing popularity.
A comprehensive review argues that BPC 157's effects on angiogenesis and nitric oxide are therapeutic assets, not risks, with anti-tumor and neuroprotective evidence.
Researchers rebut claims that BPC 157 promotes tumor growth or neurodegeneration, citing evidence it modulates—not dysregulates—angiogenesis and NO.
Pilot study finds no adverse effects from IV BPC-157 infusions in two adults, opening door for larger safety trials.
Researchers critique BPC 157 peptide literature for single-center dominance, missing dose-response data, and unverified anticancer claims.
A review argues that the cytoprotective peptide BPC 157 can simultaneously counter multiorgan failure in abdominal compartment syndrome where current drugs fall short.
A stable gastric peptide called BPC 157 may offer bidirectional vascular protection, countering both hemorrhage and thrombosis without disrupting coagulation.
Comprehensive review examines peptides like BPC-157 and TB-500 for wound healing, muscle repair, and recovery optimization in orthopedic medicine.
A 2026 systematic review finds BPC 157 heals tendons, ligaments, muscles AND their junctions without carriers, while growth factors show key gaps.
Review finds popular peptide therapies like BPC-157 and TB-500 need more rigorous human trials before clinical use.
Il Dr. Abud Bakri analizza BPC-157, epithalon, GHK-Cu, GLP-1 e i peptidi del growth hormone, separando le prove reali dall'hype.
Comprehensive analysis of clinical trials for 15 popular peptides shows which ones actually have human evidence versus hype.
Una nuova review mappa i peptidi approvati rispetto a quelli del mercato grigio nella medicina sportiva, segnalando la scarsità di dati sulla sicurezza umana alla base di composti ampiamente commercializzati.
Jim LaValle shares decades of experience with innovative peptides, metabolic testing, and personalized health optimization strategies.
A landmark scoping review identifies 87 peptides linked to sarcopenia and cachexia, revealing key signaling pathways and critical research gaps.
